Investigating the Functions of RME8 in Parkinson's Disease

NIH RePORTER · NIH · R21 · $209,375 · view on reporter.nih.gov ↗

Abstract

SUMMARY The DNAJC protein family (DNAJC5-26) is a subclass of co-chaperones that has attracted recent attention due to the identification of mutations that are linked with parkinsonism. Here, we focus on DNAJC13, which encodes Receptor-Mediated Endocytosis 8 (RME8), a co-chaperone that facilitates membrane recycling and cargo sorting of endocytosed proteins. RME8 is primarily localized at the early endosome membrane which serves as a switchboard for protein and membrane traffic. In Parkinson’s disease (PD) patients, different mutations of RME8 have been identified, however, more evidence are needed to understand the roles of RME8 in Parkinsonism in vivo. Our proposal will systematically evaluate the 1) behavioral, 2) pathological and 3) cellular changes in novel RME8 mouse models, as a function of age, and determine if they replicate PD features. Our objective is to define the functions of RME8 in Parkinsonism and identify points of therapeutic intervention for PD.

Key facts

NIH application ID
10789969
Project number
5R21NS132546-02
Recipient
YALE UNIVERSITY
Principal Investigator
Sreeganga S Chandra
Activity code
R21
Funding institute
NIH
Fiscal year
2024
Award amount
$209,375
Award type
5
Project period
2023-03-01 → 2025-02-28